JPY/USD
April 25, 2024 BY Elizabeth Anderson

Yen Backslides Against The US Dollar

This is the weakest JPY/USD performance since the mid-1990s. All eyes are now on the Bank of Japan (BOJ) as the markets expect some intervention from this monetary policymaker to bolster the yen. Don’t miss out the latest news, subscribe to LeapRate’s newsletter This currency’s weakness sparked market angst as the Japanese finance minister, Shunichi…

Read more
April 24, 2024 BY Elizabeth Anderson

Indian Regulator Looks at Adani Stock Manipulation

According to a Bloomberg report, SEBI acted against a pair of foreign portfolio investment firms. The first allegedly engaged in shorting shares of Gautam Adani’s companies after it became aware of the publication of a short-seller report from Hindenburg Research, based in the US. When this report came to light in January 2023, it decreased…

Read more
EUR USD
April 24, 2024 BY Elizabeth Anderson

EUR/USD Weaker On The Back Of Preliminary Eurozone PMI Data

A year ago, the euro was 1.100 to the US dollar. Analysts believe that a lower-than-expected value of the Hamburg Commercial Bank’s (HCOB) manufacturing PMI contributed to the feebler euro performance. The HCOB manufacturing PMI missed estimates and came in at 45.6, a decline from March 2024’s 46.5. The latest indicators also fell short of…

Read more
Tesla sign
April 23, 2024 BY Elizabeth Anderson

Tesla Cuts Prices In Major Markets

This comes after earlier price cuts in the US in the wake of tougher competition, especially since BYD, the Chinese EV maker, overtook Tesla as the foremost EV company globally. Earlier this month, the company’s Q1 financials reflected a drop in global vehicle deliveries – the first in approximately four years. Elon Musk, Tesla’s co-founder…

Read more
Grindr app
April 23, 2024 BY Elizabeth Anderson

Data Protection Lawsuit Puts Grindr in the Legal Spotlight

The users reportedly claim the gay dating app shared personal information, which included HIV statuses, with third parties. Law firm Austen Hays indicated it filed the lawsuit at the London High Court, alleging this could affect thousands of UK users. According to this filing, Austen Hays claims Grindr gave sensitive personal information to third parties…

Read more
April 22, 2024 BY Elizabeth Anderson

Blackstone ups its Proposal in Bidding War for Hipgnosis

This offer comes after Hipgnosis – a London-listed music rights investment firm – accepted Concord’s proposal. The latest Blackstone tender is the fourth augmented bid and was made on Saturday, 20 April 2024. It reportedly outstrips the Concord offer by about 7%. The latter proposed a takeover price of $1.16, which Blackstone countered with an…

Read more
Cyprus flag
April 22, 2024 BY Elizabeth Anderson

CySEC Slaps CIF MCA Intelifunds With €360,000 Fine

According to a press release on Friday, 19 April 2024, the financial watchdog’s board claims that CIF transgressed numerous regulations in the Investment Services and Activities and Regulated Markets Law of 2017. The decision follows an investigation conducted in September 2022. A breakdown of this fine includes €80,000 for not having adequate policies and procedures…

Read more
Norges Bank
April 19, 2024 BY Elizabeth Anderson

Norway’s Sovereign Wealth Fund Misses Q1 2024 Benchmark

The Norwegian sovereign wealth fund, one of the largest global investors, announced that its market value had increased to $1.6tn on Thursday, 18 April 2024. The fund further reported that most of its investments (72.1%) consisted of equities, 26% of fixed income, 1.8% of unlisted real estate, and 0.1% of renewable energy infrastructure. It reportedly…

Read more
Lilly building
April 18, 2024 BY Elizabeth Anderson

Eli Lilly’s Zepbound a Possible Treatment for Sleep Apnoea

The company markets this drug as Zepbound® in the US and as Mounjaro® in some international markets. These outcomes add to the merits of medicines such as Zepbound and Novo Nordisk’s (NVO) Ozempic in the treatment of obesity and diabetes. Despite supply, cost, and health insurance issues, these drugs remain in high demand worldwide. Lilly…

Read more